Bull/Bear Index 46.0/100
→
crypto
BULL
65/10
TokenPost · 1h ago
Precigen (PGEN), Rare Disease Drug 'PAPZIMEOS' Shows 83% Long-Term Efficacy... Accelerating Growth with $21.6 Million in Sales
Precigen (PGEN)'s rare disease drug 'PAPZIMEOS' is accelerating sales growth with 83% long-term efficacy, FDA approval, and market exclusivity, solidifying its position as the sole RRP treatment.
Catch the next bull catalyst
Telegram alerts when our AI scores a story 8+/10 (~1-3 per day, no spam). Verified 30d hit rate 50.1%.
Join Telegram channel
or scan with phone →
